(Q28285447)

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

A new X-linked dysplasia gigantism syndrome: identical with the Simpson dysplasia syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Functions of cell surface heparan sulfate proteoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Heparan sulfate proteoglycans and cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Glypican-3 as a serum marker for hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Three novel EXT1 and EXT2 gene mutations in Taiwanese patients with multiple exostoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Glycosaminoglycans and WNTs: just a spoonful of sugar helps the signal go down.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Glypicans in growth control and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Heparan sulfate: growth control with a restricted sequence menu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Report of another family with Simpson-Golabi-Behmel syndrome and a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

A new X-linked mental retardation-overgrowth syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Further delineation of the Simpson-Golabi-Behmel (SGB) syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Drosophila glypicans control the cell-to-cell movement of Hedgehog by a dynamin-independent process.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Simpson-Golabi-Behmel syndrome: genotype/phenotype analysis of 18 affected males from 7 unrelated families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Large scale deletions in the GPC3 gene may account for a minority of cases of Simpson-Golabi-Behmel syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Hedgehog signal transduction via Smoothened association with a cytoplasmic complex scaffolded by the atypical kinesin, Costal-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Identification of glypican-3 as a novel tumor marker for melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Wnt signaling in disease and in development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Role of glypican 4 in the regulation of convergent extension movements during gastrulation in Xenopus laevis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

7 January 2021

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Specificities of heparan sulphate proteoglycans in developmental processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Oligonucleotide microarray analysis of lung adenocarcinoma in smokers and nonsmokers identifies GPC3 as a potential lung tumor suppressor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Roles of heparan-sulphate glycosaminoglycans in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Expression of the cell surface proteoglycan glypican-5 is developmentally regulated in kidney, limb, and brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

The natural history of hereditary multiple exostoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Detection and clinical significance of bone marrow micrometastases in patients undergoing liver transplantation for hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

The zebrafish glypican knypek controls cell polarity during gastrulation movements of convergent extension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Glypican-3 expression in Wilms tumor and hepatoblastoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

The cell-surface proteoglycan Dally regulates Wingless signalling in Drosophila

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Natural history study of hereditary multiple exostoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Glypican-3 expression is silenced in human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

Effect of synergistic wrist motion on adhesion formation after repair of partial flexor digitorum profundus tendon lacerations in a canine model in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.10.010

10.1016/J.YEXMP.2006.10.010

7 January 2021

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

17258707

1 reference

Consolidated OpenCitations Corpus – April 2017